All years practical
| First stage | ||||
| No. | lecture title | Lecture content | hours | |
| 1 | Human Biology | The microscope | 2 | |
| The cells | 2 | |||
| The tissues (Single epithelial tissue) | 2 | |||
| Connective tissue | 2 | |||
| Muscular tissue | 2 | |||
| Nervous tissue | 2 | |||
| Bone & Cartilage | 2 | |||
| Digestive system(digestion) | 2 | |||
| Digestive system (Small & Large intestine) | 2 | |||
| Blood | 2 | |||
| The Chromosome | 2 | |||
| Cell division (Mitosis) | 2 | |||
| Cell division (Meiosis) | 2 | |||
| Excretory system | 2 | |||
| Skin | ||||
| 2 | ||||
| Analytical Chemistry | Demonstration of some laboratory equipments. | 2 | ||
| Separation and identification of group 1 cations | 2 | |||
| (individual test). | ||||
| Analysis of group 1 cataions mixture. | ||||
| 4 | ||||
| Preparation and standardization of an acid. | ||||
| 2 | ||||
| Determination of the percentage of acetic acid. | ||||
| 2 | ||||
| Analysis of sodium carbonate and sodium hydroxide mixture. | 2 | |||
| Determination of chloride by the Mohr method. | ||||
| 2 | ||||
| Determination of chloride by the Volhard | ||||
| method. | 2 | |||
| Preparation and standardization of 0.1N | ||||
| KMnO4. | 4 | |||
| Determination of ferrous form of iron in Mohr’s salt. | ||||
| Determination of total hardness in tab water. | ||||
| 2 | ||||
| Gravimetric determination of Nickel. | ||||
| 4 | ||||
| Human Anatomy | Directional term for Anatomy | 2 | ||
| Skeletal system axial skeleton | ||||
| 2 | ||||
| Skeletal system appendicular skeleton | 2 | |||
| Appendicular muscles | 2 | |||
| Axial muscles | ||||
| 2 | ||||
| Joints of the body | 2 | |||
| Circulatory system: | 2 | |||
| Location of vascular system (Heart, Arteries, Veins) | ||||
| Digestive system: | 2 | |||
| –location of different parts of digestive tract (GIT) (Oral cavity, Mouth, Esophagus & Stomach) | ||||
| -Small intestine, Large intestine, Rectum & Anus. | ||||
| Digestive system: | ||||
| Glands associated with the digestive tract by location (Salivary glands, Pancreas, Liver & Gall bladder). | ||||
| 2 | ||||
| Respiratory system: | 2 | |||
| -Conducting portion (Nose, Nasopharynx, Trachea Bronchus & Bronchioles). | ||||
| -Respiratory portion (Lung) | ||||
| Urinary system: | 2 | |||
| -location of the (kidney & nephrone) | ||||
| Nervous system: | 2 | |||
| Central & Peripheral nervous system by location | ||||
| Medical Physics | Explain how to plot graph and make laboratory | |||
| report. | 2 | |||
| Optical Fiber Loss (bend) Measurement. | ||||
| 2 | ||||
| Simple pendulum. | ||||
| 2 | ||||
| Spectral photometric | ||||
| 2 | ||||
| Density of liquid. | ||||
| 2 | ||||
| 6 | The focal length of convex lens. | |||
| 2 | ||||
| application computer in medical physics | ||||
| 2 | ||||
| Measurement of Viscosity of liquids. | ||||
| 2 | ||||
| Ostwald´s Viscometer: find viscosity of | ||||
| unknown; find the molecular | ||||
| weight; find concentration of unknown substance. | 4 | |||
| Measuring surface tension (by capillary rise | ||||
| method and traveling microscope). | ||||
| 2 | ||||
| Measuring surface tension (differential height capillary method). | ||||
| 2 | ||||
| Decay curve and half life. | ||||
| 2 | ||||
| Boyle’s Law. | ||||
| 2 | ||||
| Speed of sound. | ||||
| 2 | ||||
| Laser application for measurement of single slit. | ||||
| 2 | ||||
| Histology | Circulatory system (Artery & Vein) | 2 | ||
| Lymphatic system (Thymus gland & spleen) | 2 | |||
| Lymphatic system (Lymph node & Islet of | ||||
| Langerhans) | 2 | |||
| Nervous system (Cerebral & cerebrum cortex) | 2 | |||
| Nervous system (Spinal cord) | 2 | |||
| Respiratory system (Trachea & lung) | 2 | |||
| Digestive system (Tongue, Esophagus & | ||||
| Stomach) | 2 | |||
| Digestive system (Small & Large intestine) | 2 | |||
| Digestive system Digestive system | 2 | |||
| -Accessory glands of the digestive system (liver | ||||
| & Pancreas) | ||||
| 2 | ||||
| 7 | Endocrine system (Pituitary & Thyroid gland) | 2 | ||
| Endocrine system (Adrenal & pineal gland) | 2 | |||
| Male reproductive system (Testes & prostate | ||||
| gland) | 2 | |||
| Female reproductive system (Ovary & Uterus) | 2 | |||
| Urinary system (Kidney & Urinary bladder) | 2 | |||
| Skin (Thick & Thin skin) | 2 | |||
| organic chemsitry I | Determination of melting point (Known sample). | 2 | ||
| Determination of melting point (quiz and unknown). | 2 | |||
| Determination of boiling point (known sample). | 2 | |||
| Determination of boiling point (quiz and unknown). | 2 | |||
| Elemental analysis (explanation of basic concepts). | 2 | |||
| Elemental analysis (known quantity and quality sample). | 2 | |||
| Solution and filtration techniques (explanation of basic concepts). | 2 | |||
| Re-crystallization (known sample). | 2 | |||
| Re-crystallization (quiz and unknown sample). | 2 | |||
| Extraction technique (known sample). | 2 | |||
| Extraction technique (quiz and unknown). | 2 | |||
| Distillation techniques (known samples). | 2 | |||
| Distillation techniques (quiz and unknown). | 2 | |||
| Sublimation technique (known sample). | 2 | |||
| Sublimation technique (quiz and unknown). | 2 | |||
| Practical Pharmaceutical Calculation | Demonstration of different glass wares and equipments used in the field of pharmacy. | 2 | ||
| Pharmaceutical measurements. | 2 | |||
| Volume measurements. | 2 | |||
| Preparation of aromatic waters. | 4 | |||
| Preparation of simple solutions. | 4 | |||
| Reducing and enlarging prescription contents. | 6 | |||
| Percentages in calculating prescription contents. | 4 | |||
| Stock solutions and dilution technique during dispensing technique. | 6 | |||
| Computer science 1st semester | · Home Tab | 2 | ||
| · Modifying Spreadsheets | ||||
| · Move/Copy Cells | ||||
| · Insert Tab | 2 | |||
| Ø Tables | ||||
| Ø Illustration | 1 | |||
| Ø Charts | 2 | |||
| Ø Create a Chart | 1 | |||
| Ø Move Chart to New Sheet | ||||
| Ø Change Chart Name | ||||
| Ø Change Chart Layout | 2 | |||
| Ø Change Chart Style | ||||
| Ø Chart or Axis Titles | ||||
| Ø Data Labels | 2 | |||
| Ø Legend | ||||
| Ø Move or Resize Chart | ||||
| Ø Formatting an Excel Trendline | ||||
| Ø Reports | 2 | |||
| Ø Sparklines | 2 | |||
| Ø Filter | 2 | |||
| Ø Links | ||||
| Ø Symbols | ||||
| · Formulas Tab | 4 | |||
| Ø Function Library | ||||
| Ø Defined Names | ||||
| Ø Formula Auditing | ||||
| Ø Calculation | 2 | |||
| · Data Tab | ||||
| Ø Data tab contains 5 groups:- | ||||
| 1- Get external data | 1 | |||
| 2- Connections | 1 | |||
| 3 – Sort & filter | 1 | |||
| 4- Data Tools | 1 | |||
| 5- Outline | 1 | |||
| · Add Data Analysis | 2 | |||
| Ø T-test | ||||
| Computer science 2st semester | Introducing Operating System Window 7 | 2 | ||
| Microsoft Office Professional 2010 | 2 | |||
| Introduction Microsoft Word 2010 | 2 | |||
| Microsoft Office Interface. | ||||
| File Ribbon Tab | ||||
| Microsoft Office Quick Access Toolbar | ||||
| Appearance of Microsoft Word | ||||
| Creating a New Document | ||||
| Opening a Document | 2 | |||
| Home Tab | 2 | |||
| Insert Tab – Inserting Objects | 2 | |||
| Page Layout Tab – Document Layout | 2 | |||
| References Tab | 2 | |||
| Review Tab | 2 | |||
| Mailings Tab – Mail Merge | 2 | |||
| Introduction Power Point 2010 | 2 | |||
| Microsoft Office Interface. | 2 | |||
| File Ribbon Tab | 2 | |||
| Microsoft Office Quick Access Toolbar | 2 | |||
| Appearance of Microsoft Word | 2 | |||
| Creating a New Document | 2 | |||
| Opening a Document | 2 | |||
| Home Tab – Styling your Presentation | 2 | |||
| Insert Tab – Inserting Objects | 2 | |||
| Design Tab – Slide Layout | ||||
| Transitions Tab | ||||
| Animations Tab | 2 | |||
| Slide Show Tab | 2 | |||
| Review Tab | 2 | |||
All years theoretical
| First stage | |||||
| No. | Lecture title | Hours | |||
| Biology | 2 | ||||
| Cell | 2 | ||||
| Tissues, bone and cartilages | 3 | ||||
| Nervous system (central & peripheral) | 4 | ||||
| Nutrition | 2 | ||||
| Digestive system (Mouth, Esophagus, | |||||
| Stomach) | 2 | ||||
| Digestive system (intestine) | 1 | ||||
| Excretory system & respiration | 3 | ||||
| Human genetics (chromosomes & semi- lethal genes) | 3 | ||||
| 1 | Human Biology | Skin | 2 | ||
| Circulatory system | 3 | ||||
| Immunity (Inflammation, immunity & the | |||||
| blood , immunity to disease) | 3 | ||||
| Principles of Pharmacy Practice | Some fundamentals of measurements and | ||||
| calculations. | 4 | ||||
| Interpretation of prescription or medication orders. | 4 | ||||
| The metric system. | 4 | ||||
| Calculation of doses. | 4 | ||||
| Reducing and enlarging formulas. | 4 | ||||
| 2 | Density, specific gravity and specific volume. | 4 | |||
| Percentage and ratio strength calculation. | 6 | ||||
| Review of elementary concept important to | |||||
| analytical chemistry: Strong and weak electrolytes; important weight and concentration units. | 4 | ||||
| The evaluation of analytical data: Definition of terms | |||||
| 3 | Analytical Chemistry | An introduction to gravimetric analysis: Statistical | |||
| analysis of data; rejection of data; precipitation methods; gravimetric factor. | 9 | ||||
| The scope of applications of gravimetric analysis: | |||||
| Inorganic precipitating agents; organic precipitating agents. | 4 | ||||
| An introduction to volumetric methods of analysis: Volumetric calculations; acid-base equilibria and pH calculations. | |||||
| 5 | |||||
| Buffer solutions: Theory of neutralization titrations | |||||
| of simple system. | 3 | ||||
| Theory of neutralization titrations of complex | |||||
| system; Precipitation titrations. | 5 | ||||
| Calculation of pH in complex system; Volumetric | |||||
| methods based on complex system. | 4 | ||||
| Equilibria in oxidation-reduction system; theory of | |||||
| oxidation-reduction titrations. | 6 | ||||
| Spectrophotometric analysis: An introduction to | |||||
| optical methods of analysis; Methods based on absorption of radiation. | 4 | ||||
| Mathematics: General concepts; coordinate and graph in plane; | |||||
| inequality; absolute value or magnitude; function and their graphs; | |||||
| displacement function; slope and equation for lines. | 6 | ||||
| Limits and continuity: Limits; theorem of limits; limit involving | |||||
| infinity; continuity; continuity conditions. | |||||
| 4 | |||||
| Derivatives: Line tangent and derivatives; | |||||
| differentiation rules; | |||||
| derivative of trigonometric function; practice exercises. | 6 | ||||
| Mathematics and Biostatistics | Integration: Indefinite integrals; rules for indefinite | ||||
| integrals; integration | |||||
| formulas for basic trigonometric function; definite integrals; properties of definite integrals; practice exercises. | |||||
| 6 | |||||
| Biostatistics: General concepts of statistics; | |||||
| statistical methods; | |||||
| statistical theory; applied statistics; statistical operations. | 2 | ||||
| Probability concepts: Properties of probability; Set | |||||
| theory and set | |||||
| notation (basic notation); counting techniques- permutations and combinations; calculating the probability of an events; probability distribution of discrete variable; binomial distribution, Poisson distribution; continues probability distribution and normal distribution, review questions and exercises. | 6 | ||||
| The concept of central tendency: Mean of sample and mean of | |||||
| population; median; mode; measure of central tendency; review questions and exercises. | 6 | ||||
| Deviations and variation: Deviation; dispersion and | |||||
| variability; standard | |||||
| deviation and variance; coefficient of variations; standard error; correlation analysis.(regression model and sample regression equation); application of statistic in medical field; review questions and exercises. | 9 | ||||
| Medical Terminology | Basic word roots and common suffixes | 1 | |||
| More word roots, suffixes and prefixes related to pharmaceutical sciences (pharmacognosy, clinical pharmacy, pharmaceutics,…etc) | |||||
| 1 | |||||
| Basic anatomical terms and abnormal conditions | 2 | ||||
| The genitals and urinary tract | 1 | ||||
| The gastrointestinal tract | 1 | ||||
| The heart and cardiovascular system | |||||
| 1 | |||||
| Symptoms, diagnoses, treatments, communication | |||||
| qualifiers, and statistics | 2 | ||||
| Growth and development, and body orientation | 1 | ||||
| 6 | Gynecology, pregnancy, and childbirth | 1 | |||
| The eye and the respiratory tract | 1 | ||||
| The nervous system and behavioral disorders | 2 | ||||
| Blood and immunity | 1 | ||||
| Circulatory system: | |||||
| Location of vascular system (Heart, Arteries, Veins) | 1 | ||||
| Circulatory system: | |||||
| Location of lymphatic system (Lymphatic capillary). | 1 | ||||
| Lymphoid tissue: | |||||
| location of the (Thymus gland, Spleen & Lymph nodes) | 1 | ||||
| Lymphoid nodule (MALT) & Tonsils | 1 | ||||
| Nervous system: | |||||
| 7 | Human Anatomy | Central & Peripheral nervous system by location | 1 | ||
| Respiratory system: | |||||
| -Conducting portion (Nose, Nasopharynx, Trachea Bronchus & Bronchioles). | |||||
| -Respiratory portion (Lung) | 1 | ||||
| Digestive system: | |||||
| –location of different parts of digestive tract (GIT) (Oral cavity, Mouth, Esophagus & Stomach) | |||||
| -Small intestine, Large intestine, Rectum & Anus. | |||||
| 2 | |||||
| Digestive system: | |||||
| Glands associated with the digestive tract by location (Salivary glands, Pancreas, Liver & Gall bladder). | |||||
| 1 | |||||
| Endocrine system: | |||||
| -location of the pituitary gland | |||||
| –location of the Adrenal, Thyroid, Parathyroid, Islet of Langerhans & Pineal glands. | 1 | ||||
| Male reproductive system: | |||||
| –location of the testes. | 2 | ||||
| -Excretory genital ducts | |||||
| -Excretory genital glands (Seminal vesicles, Prostate & Cowper’s glands) | |||||
| Female reproductive system: | |||||
| -location of ovary, Oviduct, Uterus & Vagina. | 2 | ||||
| Urinary system: | |||||
| -location of the (kidney & nephrone) | 1 | ||||
| – location of the (Ureter, Bladder & Urethra). | |||||
| Dilution and concentration of pharmaceutical | |||||
| preparations. | 10 | ||||
| Pharmaceutical Calculations by Stoklosa | Isotonic solutions. | 6 | |||
| Electrolyte solutions (milliequivalents, millimoles and milliosmoles). | |||||
| 8 | 6 | ||||
| Constituted solutions, I.V admixtures and flow rate | |||||
| calculations. | 8 | ||||
| General concepts: Method of physics and | |||||
| standards; thermodynamics | |||||
| system and system properties; conservation of energy principle; | |||||
| application of thermodynamics; the Zeroth law. | 3 | ||||
| Pressure; temperature and temperature scales | |||||
| (Celsius, Fahrenheit, | |||||
| 9 | Medical Physics | Kelvin); equation of state; ideal gas and real gas; general law of gases; clauses equation and Vander Waales equation; equilibrium and types of equilibrium; compressibility factor, coefficient of volume expansion, elastic coefficient (bulk modulus). | 6 | ||
| Heat and energy; work and mechanical forms of | |||||
| work; power; the 1st | |||||
| law of thermodynamics; Boyles and Charles law; practice exercises. | 3 | ||||
| The 2nd law of thermodynamics; reversible and | |||||
| irreversible process; | |||||
| entropy and enthalpy; internal energy; heat capacity and adiabatic process; the relation between pressure, volume, and temperature in adiabatic process. | |||||
| 6 | |||||
| Fundamental of physics: Kinetic theory of a gas; electromagnetic waves; | |||||
| Maxwell equations; physical optics. | 6 | ||||
| Radiation: Kirshoffs law; planks law; Stefan- | |||||
| Boltzman law; Wiens law; | |||||
| Black body and Albedo; Heat transfer (radiation, convection, conduction). | 6 | ||||
| Production of X-Ray and X-Ray spectra; absorption | |||||
| of X-Ray; U.V and | |||||
| IR effects; medical and biological effects of radiation; radiotherapy. | 3 | ||||
| Introduction. | 3 | ||||
| Alkanes and methane. | 6 | ||||
| Alkenes I and II | 5 | ||||
| Alkynes and dienes. | 5 | ||||
| Stereochemistry I & II | 8 | ||||
| Alcohols and ethers. | 8 | ||||
| 10 | Organic Chemistry I | Alkyl halides. | 6 | ||
| Cycloalkanes. | 4 | ||||
| Circulatory system: | |||||
| Structure of the vascular system (Heart wall, Arteries, Veins & Capillaries) | 2 | ||||
| Circulatory system: | |||||
| Structure of the lymphatic system (Lymphatic capillary). | 1 | ||||
| Lymphoid tissue: | |||||
| Structure & function of the (Thymus gland, Spleen | 1 | ||||
| & Lymph nodes) | |||||
| Lymphoid nodule (MALT) & Tonsils | 1 | ||||
| 11 | Histology | Nervous system: | |||
| Central & Peripheral nervous system | 3 | ||||
| Respiratory system: | |||||
| -Conducting portion (Nose, Nasopharynx, Trachea Bronchus & Bronchioles). | |||||
| -Respiratory portion (Lung) | 3 | ||||
| Digestive system: | |||||
| –Digestive steps. | |||||
| –General structure of the digestive tract (GIT) (Oral cavity, Mouth, Esophagus & Stomach) | |||||
| -Small intestine, Large intestine, Rectum & Anus. | 3 | ||||
| Digestive system: | |||||
| Glands associated with the digestive tract (Salivary glands, Pancreas, Liver & Gall bladder0. | 1 | ||||
| Endocrine system: | |||||
| -General structure of the pituitary gland | 2 | ||||
| -Histophysiologies of the pituitary gland. | |||||
| Endocrine system: | |||||
| -General structure of the Adrenal, Thyroid, | |||||
| Parathyroid, Islet of Langerhans & Pineal glands. | 2 | ||||
| Male reproductive system: | |||||
| –General structure of the testes. | |||||
| -Stages of spermatogenesis. | 2 | ||||
| Male reproductive system: | |||||
| -Excretory genital ducts-Excretory genital glands | 1 | ||||
| (Seminal vesicles, Prostate & Cowper’sglands) | |||||
| Female reproductive system: | |||||
| -General structure of ovary, Oviduct, Uterus & Vagina. | |||||
| -Stages of follicle development. | |||||
| -Ovulation | 3 | ||||
| Urinary system: | |||||
| -Structure & Function of the (kidney & nephrone) | |||||
| -Histology of the nephrone (filtration, absorption & excretion). | |||||
| – Structure of the (Ureter, Bladder & Urethra). | 3 | ||||
| The skin | |||||
| Thick & Thin skin | 2 | ||||
| Hello | 2 | ||||
| Your world | 2 | ||||
| All about you | 2 | ||||
| English (John and Liz Soars, New Headway Plus, Oxford: Oxford | Family and friends | 2 | |||
| The way I live | 2 | ||||
| Every day | 2 | ||||
| My favorites | 3 | ||||
| Where I live | 2 | ||||
| Times past | 2 | ||||
| We had a great time | 2 | ||||
| I can do that | 2 | ||||
| Please and thank you | 2 | ||||
| Here and now | 3 | ||||
| Its time to | 2 | ||||
| Second stage | |||||
| Lecture title | |||||
| hours | |||||
| Aromatic Hydrocarbons (includes benzene, electrophilic aromatic substitution, arenas and their derivatives). | 10 | ||||
| Carboxylic acids: properties and reactions. | 5 | ||||
| Functional derivatives of carboxylic acids. | |||||
| 7 | |||||
| Amines I and II. | 6 | ||||
| 1 | Organic Chemistry II | Aldehydes and ketones (include also aldol and Claisen | |||
| condensation); Classification, reactions and properties. | 12 | ||||
| Phenols. | 5 | ||||
| Introduction: Importance of microbiology, History of microbiology | 2 | ||||
| Anatomy of bacteria: Surface appendages, Capsule, Cell wall of | |||||
| G.+ve & G –ve bacteria, Cytoplasmic membrane. | |||||
| 2 | |||||
| Bacterial physiology: Physical and chemical growth determinate, growth and growth curves, bacterial reproduction. | 3 | ||||
| Genetics: Definition, genetic, element, mutation (spontaneous, | 2 | ||||
| Gene transfer, transformation, conjugation, and gene transduction). | |||||
| Recombinant DNA biotechnology. | |||||
| Medical Microbiology, | 1 | ||||
| Sporulation and germination. | |||||
| 1 | |||||
| Sterilization (chemical + physical Methods). | |||||
| 2 | |||||
| Chemotherapy and sensitivity test | |||||
| 3 | |||||
| Staphylococci species | |||||
| 3 | |||||
| Streptococcus species | |||||
| 3 | |||||
| Aerobic Spore-forming bacteria Bacillus species (B. anthracis, B. | |||||
| subtilis, B. cereus). | |||||
| 2 | |||||
| Clostridium perfringens; Clostridium tetani; Clostridium botulinun | |||||
| 3 | |||||
| Corynebacterium diphtheriae | |||||
| 2 | |||||
| Propionibacterium acnes, Listeria | |||||
| 2 | |||||
| Mycobacterium tuberculosis; M. leprae | |||||
| 2 | |||||
| Enterobacteriaceae: (E. coli; Klebsiella spp.; Citrobacter , Serratia, Salmonella, Shigella) | |||||
| 6 | |||||
| , Vibrio, Pseudomonas, Helicobacter pylori, Neisseria spp., Brucella, Proteus, | |||||
| 6 | |||||
| The general and cellular basis of medical physiology. | 5 | ||||
| Physiology of nerves and muscles: Nerve cells; excitation | 16 | ||||
| : Physiology I | and conduction; Properties | ||||
| of mixed nerves; glia; neurotrophins; Nerve fiber types and functions; Muscles: Skeletal muscle; smooth muscle; cardiac muscle. Synaptic transmission: Reflexes; cutaneous, deep and visceral sensations; alert behavior, sleep and electrical activity of the brain; control of posture and movement; higher function of the nervous system; central regulation of visceral function; the autonomic nervous system. | |||||
| Respiration: Respiratory zones; Mechanics of respiration; air | 8 | ||||
| volumes; respiratory | |||||
| muscles; compliance of the lungs and chest wall; surfactants; differences in ventilation and blood flow in deferent parts of the lung; Dead space and uneven ventilation; Pulmonary circulation: Pressure, volume and flow. Gas transport between the lungs and tissue; Regulation of respiration: Neural control of breathing; | |||||
| Respiratory centers; Regulation of respiratory activity: Chemical factors; non chemical factors; Respiratory adjustment in health and disease; Effect of exercise; Hypoxia; Emphysema; Asthma. | |||||
| Renal Physiology: Introduction; innervations of the renal | 8 | ||||
| vessels; renal clearance; | |||||
| renal blood flow; glomerular filtration rate (GFR): Measurements; factor affecting GFR; Filtration fraction; reabsorption of Na+, Cl – and glucose. Tubuloglomerular feedback and glomerulotubular balance; water excretion in: proximal tubules; loop of henle; distal tubules; collecting ducts; the counter current mechanism; role of urea; water diuresis and osmotic diuresis; acidification of the urine: H+ secretion; reaction with buffers; ammonia secretion; factors affecting acid secretion; bicarbonate execration; regulation of Na+, K+ and Cl – excretion; uremia; acidosis; micturition. | |||||
| Cardiovascular system: origin and spread of cardiac | 8 | ||||
| excitation; the electrocardiogram; | |||||
| cardiac arrhythmias; electrographic findings in cardiac diseases; mechanical events of the cardiac cycle; cardiac output; cardiovascular regulatory mechanisms: Local regulatory mechanisms; systemic regulation by the nervous system; systemic regulation by hormones; Coronary circulation; Hypertension; Heart failure; Angina pectoris. | |||||
| States of matter, binding forces between molecules, gases, | 10 | ||||
| liquids, solid and crystalline matters; phase equilibria and phase rule; thermal analysis. | |||||
| Thermodynamics, first law, thermochemistry, second law, | 8 | ||||
| third law, free energy function and applications. | |||||
| Solutions of non-electrolytes, properties, ideal and real | 7 | ||||
| Colligative properties, molecular weight determination. | |||||
| Physical Pharmacy I | Solution of electrolytes, properties, Arrhenius theory of | 5 | |||
| dissociation, theory of strong electrolytes, ionic strength, Debye-Huchle theory, coefficients for expressing colligative properties. | |||||
| Ionic equilibria, modern theories of acids, bases and salts, | 8 | ||||
| acid-base equilibria, calculation of pH, acidity constants, the effect of ionic strength and free energy. | |||||
| Buffered and isotonic solutions: Buffer equation; buffer | 7 | ||||
| capacity; methods of adjusting tonicity and pH; buffer and biological system. | |||||
| Heterocyclic system: Classes of heterocyclic systems; | |||||
| general structures; properties; Occurrence in nature and in medicinal products. | 5 | ||||
| Five-membered ring heterocyclic compounds: pyrrole; furan | |||||
| and thiophen. | 3 | ||||
| Source of pyrrole, furan and thiophen. | 2 | ||||
| Electrophilic substitution in pyrrole, furan and thiophen: | |||||
| Reactivity and orientation. | 5 | ||||
| Organic ChemistryIII | Six-membered ring heterocyclic compounds: Structure & | ||||
| reactions of pyridine. | 4 | ||||
| Saturated five-membered heterocyclic compounds. | 6 | ||||
| Heterocyclic of five & six member rings with two & three | |||||
| heteroatoms. | 5 | ||||
| Introduction. | 1 | ||||
| Intestinal and tissue protozoa (Amoeba (pathogenic and non pathogenic), Balantidium, Giardia, Trichomonas | 4 | ||||
| Chilomastix) | |||||
| Medical Virology, immunology, and Parasitology | Haemoflagellates: Leishmania spp.; Trypanosome spp. | 4 | |||
| Sporozoa: Malarial parasites of human; Toxoplasma. | 3 | ||||
| Helminthes: Classification, Cestodes (Hymenolepis nana, Taenia spp.), Echinococcus (Hydatid cyst). | 8 | ||||
| Hepatic flukes, Trematodes (Blood Flukes: Schistosoma spp). | |||||
| Nematods: Ascaris, Entrobius. Trichuris, Ancylostoma, Necator americans. | |||||
| Virology: Introduction, Comparison between viruses and | 10 | ||||
| Bacteria and other microbes; origin of viruses, reproduction, one step growth curve, type of mutations and Classification of viruses; RNA viruses: Orthomyxo viruses; Paramyxo viruses; Retro viruses; Hepato viruses; Oncogenic viruses. DNA viruses: Herpes viridae; poxviradeae, adenoviredeae, parvoviruses | |||||
| Immunology: introduction, innate and adaptive immunity, complement, MHC molecule and autoimmune diseases, hypersensitivity, tumor immunity, immunodeficiency, immunological methods. | 15 | ||||
| Solubility and distribution phenomena, solvent-solute | 10 | ||||
| interactions, | |||||
| solubility of gases in liquids, solubility of liquids in liquids, solubility of non-ionic solids in liquids, distribution of solutes between immiscible solvents. | |||||
| Complexation, classification of complexes, methods of | 5 | ||||
| analysis, | |||||
| thermodynamic treatment of stability constants. | |||||
| Kinetics, rate and orders of reactions, influence of | 9 | ||||
| temperature and other | |||||
| factors on reactions rate, decomposition of medicinal agents and accelerated stability analysis. | |||||
| Physical PharmacyII by Alfred Martin et a | Interfacial phenomena, liquid interfaces, surface free energy, | 5 | |||
| measurement of interfacial tension, spreading coefficient, surface active agents and wetting phenomena. | |||||
| Colloids, dispersed system and its pharmaceutical | 5 | ||||
| application, types of | |||||
| colloidal systems, kinetic properties, diffusion, zeta potential, solubilization. | |||||
| Micrometrics, particle size, methods of determining particle | 3 | ||||
| size, particle shape and surface area, porosity, density. | |||||
| Rheology, Newtonian systems, thixotropy measurement, | 5 | ||||
| Negative thixotropy, determination of thixotropy. | |||||
| Polymer science, definitions pharmaceutical applications, | 3 | ||||
| molecular eight averages. | |||||
| Gastrointestinal function: Digestion and absorption of | 10 | ||||
| carbohydrates; proteins; lipids; absorption of water and electrolytes; vitamins and minerals; regulation of gastrointestinal function: Introduction; gastrointestinal hormones; mouth and esophagus; stomach; exocrine portion of the pancreas; liver and biliary system; small intestine; colon. | |||||
| Circulatory body fluid: Introduction; blood; bone marrow; | 15 | ||||
| Physiology II | white blood cells; immunity; platelets; red blood cells; anemia; polycythemia; blood group and Rh factor; hemostasis: The clotting mechanism / blood coagulation tests; anti clotting mechanism; the plasma; the lymph; abnormalities of hemostasis. | ||||
| Endocrinology: Introduction; energy balance, metabolism | 20 | ||||
| and nutrition; the pituitary gland; the thyroid gland; the gonads: development and function of the reproductive system; the adrenal medulla and adrenal cortex; hormonal control of calcium metabolism and the physiology of the bone; endocrine functions of the pancreas and regulation of carbohydrate metabolism. | |||||
| Getting to know you. | 2 | ||||
| The way we live | 2 | ||||
| It all went wrong | 2 | ||||
| Let’s go shopping | 2 | ||||
| What do you want to do? | 2 | ||||
| Tell me! What’s it like? | 2 | ||||
| English | Famous couples | 2 | |||
| Do’s and Don’ts | 2 | ||||
| Liz and John Soar, New Headway Plus – Pre-Intermediate. Oxford: Oxford University Press | Going places | 2 | |||
| Scared to death | 2 | ||||
| Things that changed the word | 3 | ||||
| Dreams and reality | 3 | ||||
| Earning living | 2 | ||||
| Love you and leave you | 2 | ||||
| General Introduction: The Scope of Pharmacognosy, | 3 | ||||
| definitions and basic principles. | |||||
| Drugs from natural sources, crud drugs, official and non- | 1 | ||||
| official drugs. | |||||
| Classification of natural products. | 2 | ||||
| Plant nomenclature and taxonomy. | 2 | ||||
| Production of crude drugs: Cultivation, collection, drying | 3 | ||||
| and storage. | |||||
| Deterioration of crude natural products. | 1 | ||||
| Chemistry of natural drug products. | 3 | ||||
| Quality control: Evaluation of natural products; | 4 | ||||
| Pharmacognosy I | macroscopical evaluation; physical evaluation; chemical evaluation; biological evaluation; spectroscopical evaluation. | ||||
| Phytochemical investigation of herbal products: Extraction | 4 | ||||
| of the plant material; Separation and isolation of constituents; characterization of the isolated compounds. | |||||
| Separation technique: Introduction; Mechanisms of | 15 | ||||
| separation and classification based on the type of technique; paper chromatography; Thin layer chromatography; Ion- exchange chromatography; Gel filtration chromatography; Column chromatography; Gas chromatography; HPLC; Electrophoresis; Affinity chromatography. | |||||
| Traditional plant medicines as a source of new drugs. | 3 | ||||
| Bioassay-guided fractionation | |||||
| Third stage | |||||
| ةداملا | Lecture title | ||||
| hours | |||||
| Atomic and molecular structure/ Complexation. | 6 | ||||
| Essential and trace ions: Iron, copper, sulfur, iodine. | 3 | ||||
| Non essential ions: Fluoride, bromide, lithium, gold, silver and | |||||
| mercury. | 2 | ||||
| Gastrointestinal agents: Acidifying agents. | 1 | ||||
| Antacids. | 2 | ||||
| Protective adsorbents. | 1 | ||||
| Topical agents. | 2 | ||||
| Inorganic Pharmaceutical Chemistry | Dental agents. | ||||
| 1 | |||||
| Radiopharmaceutical preparations. | 6 | ||||
| Radio opaque and contrast media. | 6 | ||||
| Introduction: General biosynthesis pathways of secondary | |||||
| metabolites. | 2 | ||||
| Carbohydrates. | |||||
| 2 | |||||
| Glycosides: Biosynthesis, physical and chemical properties; cardiac | |||||
| Pharmacognosy II | glycosides; saponin glycosides; anthraquinone glycosides; flavonoid glycosides; cyanophore lycosides. | 5 | |||
| Glycosides: Isothiocyanate glycosides; aldehyde glycosides; alcoholic | |||||
| glycosides; phenolic glycosides; lactone glycosides; coumarins and chromones. | 5 | ||||
| Resins and resin combination; tannins. | |||||
| 2 | |||||
| Lipids: fixed oils and waxes. | |||||
| 3 | |||||
| Volatile oils: Introduction; chemistry of volatile oils; biosynthesis of | |||||
| volatile oils; hydrocarbons as volatile oils; alcohols as volatile oils; aldehydes as volatile oils. | 4 | ||||
| Ketones as volatile oils; Phenols as volatile oils; Oxides as volatile | |||||
| oils; Ester as volatile oils; Phenolic ethers as volatile oils. | 3 | ||||
| Non- medicinal toxic plants. | 2 | ||||
| Vitamins and Amino acids. | |||||
| 2 | |||||
| Dispersed systems: their classification; comparisons between | 2 | ||||
| different systems. | |||||
| Solutions and types of solutions. | 2 | ||||
| Solubility: Factors affecting solubility; expression of dissolution; | 4 | ||||
| dissolution rate versus solubility; preparation of solutions containing non-volatile materials. | |||||
| Official solutions; classification of official solutions; preparation and | 4 | ||||
| uses. | |||||
| Aqueous solutions containing aromatic principles; aromatic waters; | 4 | ||||
| methods of preparations; stability. | |||||
| Syrups: sugar based syrups; artificial and sorbitol based syrups; | 4 | ||||
| stability of syrups. | |||||
| Definition and methods of clarification; filter aids in clarification. | 3 | ||||
| Pharmaceutical Technology I | Preparation of solutions using mixed solvent systems; spirits, and | 3 | |||
| elixirs. | |||||
| Extraction; maceration and percolation. | 3 | ||||
| Tinctures; fluid extracts; extracts of resins and oleoresins. | 4 | ||||
| Colloidal dispersions; lyophilic; lyophobic. | 6 | ||||
| Coarse dispersion; suspensions. | 6 | ||||
| Introduction to the macromolecules biochemistry: Definitions and | 2 | ||||
| terms; proteins, enzymes, DNA; Clinical value. | |||||
| Amino acids: Structures of A.A (table of standard A.A abbreviation | 3 | ||||
| Biochemistry I | and | ||||
| side chain); Classification, properties, isomerism. | |||||
| Amino acids: Chemical reactions, Zwitter ions, titration curve | |||||
| calculating isoelectric point values. Examples and questions. Non standards A.A: Structures, existence and clinical value. | 3 | ||||
| Peptides: Peptide bond, resonance forms, isomers, physical properties | |||||
| and chemical reactions. Essential poly peptides in human body, structures, roles and clinical values. | 3 | ||||
| Proteins: Structure and conformations of proteins, Primary structure, | |||||
| Secondary structure (4 helix, 5 sheet), tertiary structure, quaternary structure. Classification, synthesis, cellular functions (Enzymes, cell signaling, and ligand transport, structural proteins), protein in nutrition. | 3 | ||||
| Denaturation of proteins and protein sequencing: Determining A.A | 3 | ||||
| composition, N- terminal A.A analysis, C- terminal A.A analysis, Edman degradation, prediction protein sequence from DNA/ RNA sequences. Methods of protein study: Protein purification, cellular localization, proteomics and bioinformatics, structure predication and simulation. | |||||
| Carbohydrates: Chemistry and classification, biomedical importance, | 3 | ||||
| classification of CHO, Stereochemistry of monosaccharides, metabolism of CHO; Physiologically important monosaccharides, glycosides, disaccharides, polysaccharides. | |||||
| Lipids: Introduction, classification of lipids, fatty acids (F.A), | 3 | ||||
| nomenclature of F.A, saturated F.A, unsaturated F.A, physical and physiological properties of F.A, metabolism of lipids. Phospholipids, lipid peroxidation and antioxidants, separation and identification of lipids, amphipathic lipids. | |||||
| Enzymes: Structures and mechanism, nomenclature, classification, | 3 | ||||
| mechanisms of catalysis, thermodynamics, specificity, lock and key model, induced fit model, transition state stabilization, dynamics and function, allosteric modulation. Biological function, cofactors, coenzymes, involvement in disease. | |||||
| Kinetics: General principles, factors effecting enzyme rates (substrate | 2 | ||||
| conc., pH, temperature, etc), single-substrate reaction (Michaelis- Menten kinetics), kinetic constants. Examples of kinetic questions and solutions. | |||||
| Enzyme inhibition: Reversible inhibitors, competitive and non | 1 | ||||
| competitive inhibition, mixed-type inhibition, Irreversible inhibition. Inhibition kinetics and binding affinities (ki), questions and solutions. | |||||
| Control of activity and uses of inactivators; multi-substrate reactions, | 1 | ||||
| ternary-complex mechanisms, ping-pong mechanisms, non- Michaelis- Menten kinetics, pre-steady-state kinetics, chemical mechanisms. | |||||
| Nucleic Acid: Chemical structure, nucleic acid components, nucleic | 3 | ||||
| acid bases, nucleotides and deoxynucleotides (Properties, base pairing, sense and antisense, super-coiling, alternative structures, quadruple structures. | |||||
| Biological functions of DNA: Genes and genomes, transcription and | 2 | ||||
| translation, replication. | |||||
| Biochemistry of extracellular and intracellular communication: | 3 | ||||
| Plasma | |||||
| membrane structure and function; Biomedical importance, membrane proteins associated with lipid bilayer, membranes protein composition, dynamic structures of membranes, a symmetric structures of membranes. | |||||
| Artificial membranes model, the fluid mosaic model, membrane | 1 | ||||
| selectivity, physiological functions of plasma membranes. | |||||
| Biochemistry of the endocrine system: Classification of hormones, | 3 | ||||
| biomedical importance, the target cell concept and hormone receptors, biochemistry of hormone action and signal transduction. | |||||
| Special topics: Nutrition, digestion, and absorption. Biomedical | 3 | ||||
| importance, digestion and absorption of carbohydrates, lipids, proteins, vitamins and minerals; energy balance. Biochemistry of hemostasis and clot formation. | |||||
| Introduction. | 1 | ||||
| Cell injury and tissue response; Degeneration; Necrosis; Atrophy; | 6 | ||||
| Hypertrophy; Metaplasia and Calcification; Inflammation and Repair. | |||||
| Disorders of electrolytes and water and acid–base balances: Hyper | 4 | ||||
| and | |||||
| Pathophysiology | Hyponatremia; Hyper and Hypokalemia; Syndrome of inappropriate secretion of ADH; Diabetes insipidus; Metabolic acidosis and alkalosis; Respiratory acidosis and alkalosis. | ||||
| Disorders of cardiovascular system: Hyperemia; Congestion and | 5 | ||||
| edema; | |||||
| Thrombosis; embolism and infarction; Shock; Coronary heart disease and MI; Rheumatic heart disease; Heart failure; Acute pulmonary edema; Essential hypertension; Secondary hypertension; Malignant hypertension; Hypotension; Aneurysm versus varicose veins; | |||||
| Disorders of respiratory system: Pneumonias; Tuberculosis; | 3 | ||||
| Respiratory | |||||
| distress syndrome; Bronchial asthma; Emphysema and bronchiectasis; Cystic fibrosis; Pulmonary embolism; Pulmonary hypertension. | |||||
| Disorders of the renal system: Nephrotic syndrome; | 4 | ||||
| Glomerulonephritis; | |||||
| Diabetic glomerulosclerosis; Hypertensive glomerular disease; Pyelonephritis; Drug related nephropathies; Acute renal failure; Chronic renal failure. | |||||
| Disorders of GI and hepatobiliary systems: Peptic ulcer and Zollinger | 4 | ||||
| –Ellison syndrome; Irritable bowel syndrome; Crohn’s disease; Diarrhea; Celiac disease; Viral hepatitis; Primary biliary cirrhosis; Liver failure; Cholelithiasis. | |||||
| Disorders of thyroid function: Hypothyroidism. Hyperthyroidism. | 2 | ||||
| Graves’s disease. Thyrotoxicosis. | |||||
| Disorders of adrenal function: Cushing syndrome. Adrenal cortical | 2 | ||||
| Insufficiency (primary and secondary). Congenital adrenal hyperplasia. Pheochromocytoma. | |||||
| Diabetes mellitus and metabolic syndrome; | 3 | ||||
| Dyslipoproteinemia. | 2 | ||||
| Neoplasia | 4 | ||||
| Metabolic &rheumatic disorders of skeletal system: | 2 | ||||
| -Osteoporosis, osteomalacia & rickets, rheumatoidarthritis, systemic lupus erythromatosus, ankylosing spondylitis, gout, osteoarthritis syndrome. | |||||
| Alterations in the immune response (pathophysiology of immunopathology): | |||||
| – Hypersensitivity disorders. | |||||
| – Transpalantation immunopathology. | 3 | ||||
| – Immunodeficiency disorders. | |||||
| Drug distribution. | 4 | ||||
| Acid- base properties. | 3 | ||||
| Statistical prediction of pharmacological activity. | 3 | ||||
| QSAR models. | 2 | ||||
| Molecular modeling (Computer aided drug design). | 1 | ||||
| Drug receptor interaction: force involved. | 1 | ||||
| Steric features of drugs. | 2 | ||||
| Optical isomerism and biological activity. | 1 | ||||
| Calculated conformation. | 1 | ||||
| Three- dimensional quantitative structure activity relationships and | 1 | ||||
| databases. | |||||
| Isosterism. | 1 | ||||
| Drug-receptor interaction and subsequent events. | 1 | ||||
| Organic Pharmaceutical Chemistry I | General pathways of drug metabolism: Sites of drug | 22 | |||
| biotransformation; Role of cytochrome P450 mono-oxygenases in oxidative biotransformation; Oxidative reactions; Reductive reactions; Hydrolytic reactions; Phase II reactions. | |||||
| Factors affecting drug metabolism. | 2 | ||||
| General introduction to Pharmacology. | 2 | ||||
| Pharmacokinetics. | 4 | ||||
| pharmacology I | Drug Receptor interaction and Pharmacodynamics. | 4 | |||
| The autonomic nervous system (ANS). | 2 | ||||
| Cholinergic system. | 6 | ||||
| Adrenergic system. | 6 | ||||
| Principal of antimicrobial therapy. | 2 | ||||
| β- lactam and other cell wall synthesis inhibitor antibiotics | 4 | ||||
| Protien synthesis inhibitors | 4 | ||||
| Quinolones, Folate antagonists, and urinary tract antiseptics. | 3 | ||||
| Antimycobacterium drugs | 2 | ||||
| Antifungal drugs. | 2 | ||||
| Antiprotozoal drugs. | 1 | ||||
| Anthelmintic drugs. | 2 | ||||
| Antiviral drugs. | 1 | ||||
| Emulsions; purpose of emulsification; methods of emulsification; | 10 | ||||
| emulsifying agents; HLB system; stability of emulsions. | |||||
| Lotions; liniments and collodions. | 5 | ||||
| Suppositories. | 6 | ||||
| Powdered dosage forms. | 10 | ||||
| Semisolid dosage forms. | 10 | ||||
| Pharmaceutical Technology II | Incompatibilities in pharmaceutical dosage forms. | 4 | |||
| Bioenergetics. | 2 | ||||
| Biologic oxidation. | 2 | ||||
| The respiratory chain and oxidative phosphorylation. | 2 | ||||
| Over view of metabolism. | 2 | ||||
| Citric acid Cycle. | 2 | ||||
| Glycolysis. | 2 | ||||
| Metabolism of glycogen. | 4 | ||||
| Gluconeogenesis. | 3 | ||||
| Pentose phosphate pathway and other pathways of hexose | 3 | ||||
| Biochemistry II | metabolism. | ||||
| Biosynthesis of fatty acids. | 3 | ||||
| Oxidation of fatty acids. | 2 | ||||
| Metabolism of acylglycerol and sphingolipids. | 2 | ||||
| Lipid transport and storage. | 2 | ||||
| Cholesterol synthesis, transport, and excretion. | 2 | ||||
| Biosynthesis of the Nutritionally Nonessential Amino Acids. | 3 | ||||
| Catabolism of Proteins & of Amino Acid Nitrogen | 3 | ||||
| Catabolism of the Carbon Skeletons of Amino Acids. | 2 | ||||
| Conversion of Amino Acids to Specialized Products. | 2 | ||||
| Porphyrins & Bile Pigments | 2 | ||||
| Alkaloids: Introduction; Physical and chemical properties; pyridine, | 5 | ||||
| piperidine alkaloids; tropane alkaloids. | |||||
| Alkaloids: Quinoline tropan alkaloids; iso-quinoline alkaloids; | 5 | ||||
| imidazole alkaloids; indole alkaloids. | |||||
| Alkaloids: Steroidal alkaloids; lupinane alkaloids; alkaloidal amines; | 4 | ||||
| Pharmacognosy III | purine alkaloids. | ||||
| Antibiotics: Natural sources; biosynthetic pathways, isolation and | 6 | ||||
| purification. | |||||
| .phytotherapy :Introduction , principles,medicinal plants in selected | 10 | ||||
| health care systems.Important natural products & phytomecines used in pharmacy & medicine | |||||
| Introduction to Pharmacy Ethics (Theoretical considerations). | 2 | ||||
| Code of Ethics for Pharmacists. | 1 | ||||
| Common Ethical Considerations in Pharmaceutical Care Practice | |||||
| (Beneficence, Autonomy, Honesty, Informed Consent, Confidentiality, Fidelity ………). | 3 | ||||
| Interprofessional Relations. | 2 | ||||
| Making ethical decisions. | 1 | ||||
| Ethical issues related to clinical pharmacy research. | 1 | ||||
| Ethical problems in the pharmacist’s clinical practice. | 1 | ||||
| Preventing misuse of medicines. | 1 | ||||
| Case studies in pharmacy ethics. | 3 | ||||
| Fourth stage | |||||
| Lecture title | hours | ||||
| Pharmacology II | Introduction to CNS pharmacology. | 2 | |||
| CNS stimulants. | 2 | ||||
| Anxiolytic and Hypnotic drugs. | 3 | ||||
| General and Local Anesthetics. | 3 | ||||
| Antidepressant drugs. | 3 | ||||
| Antipsychotic (neuroleptic) drugs. | 3 | ||||
| Opioid analgesics and antagonists. | 3 | ||||
| Treatment of neurodegenerative diseases. | 3 | ||||
| Antiepileptic Drugs. | 2 | ||||
| Diuretics. | 2 | ||||
| The treatment of heart failure (HF). | 2 | ||||
| Antiarrhythmic drugs. | 2 | ||||
| Antianginal Drugs. | 2 | ||||
| Antihypertensive drugs. | 3 | ||||
| Drugs affecting the blood. | 3 | ||||
| Antihyperlipidemic drugs. | 2 | ||||
| Gastrointestinal and antiemetic drugs. | 2 | ||||
| Drugs acting on the respiratory system. | 3 | ||||
| Cholinergic agents, cholinergic receptors and their subtypes. | 3 | ||||
| Cholinergic agonists; stereochemistry and structure-activity | 5 | ||||
| relationships (SAR); products; cholinesterase inhibitors. | |||||
| organic pharmaceutical chemistry | Cholinergic blocking agent; structure-activity relationships (SAR); | 5 | |||
| Solanaceous alkaloid and analogues; synthetic cholinergic blocking agents and products; ganglionic blocking agents (neuromuscular blocking agents). | |||||
| Analgesic agents (SAR of morphine, SAR of meperidine type | 5 | ||||
| molecules; SAR of methadone type compounds; N- methylbezomorphans, antagonist type analgesics in benzomorphans). | |||||
| Analgesic receptors, endogenous opioids; Products; Antitusive | 5 | ||||
| agents; Anti-inflammatory analgesics. | |||||
| Adrenergic agents (Adrenergic neurotransmitters); Adrenergic | 8 | ||||
| receptors; Drugs affecting Adrenergic neurotransmission; Sympathomimetic agents; Adrenergic receptor antagonists. | |||||
| CNS depressant; Benzodiazepines and related compounds; | 7 | ||||
| Barbiturates; CNS depressant with skeletal muscle relaxant properties; Antipsycotics; Anticonvulsants. | |||||
| CNS Stimulants | 3 | ||||
| Steroidal & nonsteroidal hormones | 4 | ||||
| Introduction to community pharmacy. | 1 | ||||
| Respiratory problems: Cough, Common cold, allergic rhinitis, Otitis media, Laryngitis & Pharyngitis | |||||
| 3 | |||||
| G.I.T problemse: Diarrhea, Constipation, Heart burn and indigestion, IBS and Hemorrhoids | |||||
| 4 | |||||
| Pediatric care practice : Oral thrush, pinworms and head lice | 2 | ||||
| Skin conditions: Acne, Scabies, Psoriasis, Hair loss, Fungal | |||||
| infection, Eczema and Dermatitis , Dandruff, Cold sore, Corns and Callus. | 5 | ||||
| Women’s health care: Cystitis and vaginal thrush, primary | |||||
| dysmenorrhea and Premenstrual syndrome. | |||||
| 2 | |||||
| CNS related problems: Headache, Insomnia, Motion sickness, Nausea and vomiting | 3 | ||||
| – Eye problems | 1 | ||||
| ENT problems | 1 | ||||
| Clinical Pharmacy1 | Oral hygiene, mouth ulcer | 1 | |||
| Obesity and body weight control. | 1 | ||||
| – Pain and musculoskeletal disorders | 1 | ||||
| Nicotine replacement therapy ( NRT). | 1 | ||||
| Dietary supplements | 1 | ||||
| An update in reclassification of OTC drugs ( simvastatin, Tamusotisin & azithromycin). | |||||
| 2 | |||||
| Medication adherence and errors. | 1 | ||||
| Introduction to biopharmaceutics. | 2 | ||||
| Biopharmaceutics | Biopharmaceutic aspects of products; drug absorption; | 6 | |||
| mechanisms of | |||||
| absorption; physicochemical factors; dissolution rate; effects of excipients; type of dosage forms. | |||||
| One compartment open model. | 2 | ||||
| Multicompartment models. | 2 | ||||
| Pharmacokinetics of drug absorption. | 2 | ||||
| Bioavailability and bioequivalence. | 2 | ||||
| Clearance of drugs from the biological systems. | 2 | ||||
| Hepatic elimination of drugs. | 2 | ||||
| Protein binding of drugs. | 2 | ||||
| Intravenous infusion | 2 | ||||
| Multiple dosage regimens. | 2 | ||||
| Non-linear pharmacokinetics. | 2 | ||||
| Dosage adjustment in renal diseases. | 2 | ||||
| Introduction: The scope and concerns of public health, health care system in Iraq | 1 | ||||
| Measuring, Monitoring, and Evaluating the Health of a Population | 1 | ||||
| Population screening and public health | 1 | ||||
| Prevention and control of non-communicable diseases | 1 | ||||
| Principles of infectious disease control | 1 | ||||
| National immunization plan of Iraq. | 1 | ||||
| Communicable diseases (infections through the gastro-intestinal tract, Infections through skin and mucous membranes, Infections through the respiratory tract) | 1 | ||||
| Prevention and control of public health hazards ( Tobacco, alcohol, Public health aspects of illicit psychoactive drug use) | 1 | ||||
| Major health problems (Obesity, Physical activity and health, Public mental health and suicide, Dental public health, Sexually transmitted infections, Chronic hepatitis and other liver disease, Tuberculosis …) | 2 | ||||
| Nutritional disorders | 1 | ||||
| Family health | 1 | ||||
| Environmental health | 1 | ||||
| Occupational health | 1 | ||||
| Public Health | Travel health | 1 | |||
| Introduction: a historic background of pharmacy practice. | 1 | ||||
| Pharmacy Practice and the health care system | 2 | ||||
| Health promotion in community pharmacy | 1 | ||||
| Introduction to Pharmaceutical care | 1 | ||||
| Pharmaceutical care planning | 2 | ||||
| Community pharmacy management | 1 | ||||
| Hospital pharmacy service. | 1 | ||||
| Biosafety in pharmacy practice | 2 | ||||
| Formulary management and Regulatory affairs | 2 | ||||
| Rational Use of Drugs | 2 | ||||
| Principles and Elements of Interpersonal Communication | 2 | ||||
| Communication Skills | |||||
| Nonverbal type of communication. | 2 | ||||
| Barriers to communication. | 2 | ||||
| Listening and empathic responding during communication. | 2 | ||||
| Assertiveness. | 2 | ||||
| Interviewing and assessment. | 2 | ||||
| Helping patients to manage therapeutic regimens. | 2 | ||||
| Patient counseling; counseling check list; point-by-point | |||||
| discussion; | |||||
| counseling scenario. | 2 | ||||
| Medication safety and communication skills. | 2 | ||||
| Strategies to meet specific needs. | 2 | ||||
| Communicating with children and elderly about | |||||
| medications. | 2 | ||||
| Communication skills and inter-professional collaboration. | 2 | ||||
| Electronic communication in healthcare. | 2 | ||||
| Ethical behavior when communicating with patients. | 2 | ||||
| Travel health | 1 | ||||
| Health insurance | 1 | ||||
| Hormones of the pituitary and thyroid glands. | 3 | ||||
| Insulin and oral hypoglycemic drugs. | 4 | ||||
| Adreno-corticosteroids. | 3 | ||||
| The gonadal hormones and inhibitors. | 3 | ||||
| Autacoids and autacoid antagonists | 3 | ||||
| Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti- | 3 | ||||
| inflammatory agents. | |||||
| Drugs used in erectile dysfunction. | 2 | ||||
| Drugs used in osteoporosis. | 2 | ||||
| Pharmacology III | Drugs used in the management of obesity. | 2 | |||
| Cancer Chemotherapy: Anticancer drugs and | 5 | ||||
| immunosuppressants. | |||||
| Organic Pharmaceutical | β-Lactam antibiotics (Penicillins); β-Lactamase inhibitors; | 9 | |||
| Chemistry III | Cephalosporins and Monobactams. | ||||
| Aminoglycosides and Chloramphenicol; Tetracylines; Macrolides; | 9 | ||||
| Lincomycins and Polypeptides; Antiviral agents (properties of viruses, viral classification, products). | |||||
| Sulfonamides (chemistry, nomenclature, mechanism of action, | 4 | ||||
| resistance, toxicity, side effects, metabolism, protein binding, distribution and SAR); products; Sulfones. | |||||
| Anti-neoplastic agents: Alkylating agents; Antimetabolites; | 17 | ||||
| Antibiotics; Plant products; Miscellaneous compounds. | |||||
| Hormones and related compounds; Future anti-neoplastic agents; | 6 | ||||
| Monoclonal antibodies; Gene therapy of cancer. | |||||
| Introduction to the concept of clinical pharmacy- its activities and professional responsibilities.( including current state of clinical pharmacy in Iraq) . | 1 | ||||
| Clinical Pharmacy II | overview of pharmaceutical care practice (the patient care | ||||
| process). | 1 | ||||
| Hematologic disorders: Anemia and sickle cell disease. | 2 | ||||
| Hypertension. | 2 | ||||
| Ischemic heart diseases | 2 | ||||
| Heart failure. | 2 | ||||
| Peripheral vascular diseases. | 1 | ||||
| – Asthma. | 2 | ||||
| Chronic obstructive pulmonary disease ( COPD ). | 1 | ||||
| Diabetes mellitus & Diabetic ketoacidosis (DKA) . | 2 | ||||
| Peptic ulcer disease. | 2 | ||||
| Tuberculosis | 1 | ||||
| Infective meningitis | 1 | ||||
| Respiratory tract infections | 2 | ||||
| GIT infections | 1 | ||||
| Gout and hyperuricemia | 1 | ||||
| Rheumatoid arthritis (RA) and osteoarthritis (OA) | 2 | ||||
| Osteoporosis and other metabolic bone disease. | 1 | ||||
| Infectious Endocarditis | 1 | ||||
| Surgical antibiotic prophylaxis | 1 | ||||
| Urinary tract infection (UTI) | 1 | ||||
| Introduction: general consideration; host factor, environmental | 3 | ||||
| factors | |||||
| of toxic effects. | |||||
| Carcinogenesis. | 3 | ||||
| Mutagenesis: | 1 | ||||
| Target organs and systemic toxicology; Respiratory system, Liver, | 16 | ||||
| Kidney, Skin, Nervous system, cardiovascular system, Blood. | |||||
| General Toxicology | Toxic substances: Food additive and contaminants, Pesticides, | 15 | |||
| Metals, | |||||
| Radiation and radio active materials, plants, Solvents, | |||||
| Environmental toxicology: Air pollution, water and soil pollutants, | 7 | ||||
| Gases (Tear gas, Pepper spray), CO, Cyanide(H2S). | |||||
| Principles of pharmaceutical processing; mixing; fluid mixing; | 7 | ||||
| flow | |||||
| characteristics; mechanisms of mixing; mixing equipments; batch and continuous mixing; mixer selection; solid mixing theory and particulate solid variables; forces and mechanisms. | |||||
| Industrial Pharmacy I | |||||
| Milling; pharmaceutical application; size measurement methods; | 7 | ||||
| theory | |||||
| and energy of commenution; types of mills; factors influencing milling; | |||||
| selection of mill techniques; specialized drying methods. | |||||
| Drying: definition; purpose; humidity measurement; theory of | 7 | ||||
| drying; | |||||
| drying of solids, and classification of dryer; specialized drying methods. | |||||
| Clarification and filtration: Theory; filter media; filter aids; | 7 | ||||
| selection of | |||||
| drying method; non-sterile and sterile operations; integrity testing; equipments and systems (commercial and laboratory). | |||||
| Sterilization; validation of methods; microbial death kinetics; | 7 | ||||
| methods | |||||
| of sterilization (thermal and non-thermal); mechanisms; evaluation. | |||||
| Pharmaceutical dosage form design; pre-formulation; preliminary | 3 | ||||
| evaluation; bulk characterization; solubility and stability analysis. | |||||
| Pharmaceutical dosage forms; sterile products; development; | 7 | ||||
| formulation; production; processing; quality control. | |||||
| Fifth stage | |||||
| Lecture title | |||||
| hours | |||||
| Basic concept of prodrugs; Covalent bonds (cleavable); Prodrugs of | 6 | ||||
| functional groups; Types of prodrugs. | |||||
| Chemical delivery systems; Polymeric prodrugs; Types and structure | |||||
| of polymers; Cross-linking reagents. | |||||
| Organic Pharmaceutical Chemistry IV | Drug targeting. | ||||
| 4 | |||||
| Project. | |||||
| 4 | |||||
| Combinatorial chemistry; Peptides and other linear structures; Drug | |||||
| like molecules; Support and linker; Solution-phase combinatorial chemistry. | |||||
| 5 | |||||
| Detection, purification and analgesics; Encoding combinatorial | |||||
| libraries; | |||||
| High-throughput screening; Virtual screening; Chemical diversity and library design. | 5 | ||||
| Pharmaceutical dosage forms: Tablets; role in therapy; advantages | |||||
| and | |||||
| disadvantages; formulation; properties; evaluation; machines used in tableting; quality control; problems; granulation, and methods of production; excipients, and types of tablets. | |||||
| 10 | |||||
| Tablet coating; principles; properties; equipments; processing; types | |||||
| of | |||||
| coating (sugar and film); quality control, and problems. | 4 | ||||
| Capsules: Hard gelatin capsules; materials; production; filling | |||||
| equipments; formulation; special techniques. | |||||
| 3 | |||||
| Soft gelatin capsules: Manufacturing methods; nature of capsule shell | |||||
| and content; processing and control; stability. | 2 | ||||
| Micro-encapsulation; core and coating materials; stability; | |||||
| Industrial Pharmacy II | equipments | ||||
| and methodology. | 2 | ||||
| Modified (sustained release) dosage forms; theory and concepts; | |||||
| evaluation and testing; formulation. | |||||
| 3 | |||||
| Liquids: Formulation; stability and equipments. | 3 | ||||
| Suspensions: Theory; formulation and evaluation. | |||||
| 3 | |||||
| Emulsions: Theory and application; types; formulation; equipments | |||||
| and | |||||
| quality control. | 3 | ||||
| Semisolids: Percutaneouse absorption; formulation; types of bases | |||||
| (vehicles) preservation; processing and evaluation. | |||||
| 3 | |||||
| Suppositories: Rectal absorption; uses of suppositories; types of | |||||
| bases; | |||||
| manufacturing processes; problems and evaluation. | 3 | ||||
| Pharmaceutical aerosols: Propellants; containers; formulation; types | |||||
| and | |||||
| selection of components; stability; manufacturing; quality control and testing. | 6 | ||||
| Interpretation of Lab. data. | 2 | ||||
| Acute coronary syndrome. | 2 | ||||
| Therapeutic I | Arrhythmias | 2 | |||
| Thrombosis | 2 | ||||
| Dyslipidemia | 1 | ||||
| Stroke | 2 | ||||
| Shock | 2 | ||||
| Liver cirrhosis | 2 | ||||
| Viral hepatitis | 1 | ||||
| Inflammatory bowel diseases | 2 | ||||
| Acute renal failure (ARF) | 1 | ||||
| Chronic renal failure (CRF) | 2 | ||||
| Hemodialysis and peritoneal dialysis | 1 | ||||
| Systemic lupus erythematosis (SLE) | 1 | ||||
| Benign prostatic hyperplasia (BPH) | 1 | ||||
| Acid – base disorders | 2 | ||||
| Disorders of fluid and electrolytes | 2 | ||||
| Urinary incontinence and pediatric enuresis | 1 | ||||
| Epilepsy and status epilepticus | 2 | ||||
| multiple sclerosis | 1 | ||||
| Parkinson’s disease | 2 | ||||
| Pain management | 2 | ||||
| Headache disorders | 1 | ||||
| glucoma | 2 | ||||
| Parenteral nutrition | 2 | ||||
| Enteral nutrition | 2 | ||||
| Pharmacovigilance | 2 | ||||
| Disorders of Carbohydrates metabolism, Hyperglycemia & Diabetes | |||||
| mellitus, Hypoglycemia. | |||||
| 3 | |||||
| Disorders of lipid metabolism. | |||||
| 2 | |||||
| Liver Function Tests. | |||||
| 4 | |||||
| Clinical Chemistry | Kidney Function Tests. | ||||
| 4 | |||||
| Diagnostic enzymology. | |||||
| 4 | |||||
| Hypothalamus & pituitary endocrinology, disorders of anterior | |||||
| pituitary hormones, disorders of adrenal gland, hypopituitrism. | |||||
| 8 | |||||
| Reproductive system, disorders of gonadal function in males & | |||||
| females, biochemical assessment during pregnancy. | |||||
| 5 | |||||
| Tumor markers. | |||||
| 4 | |||||
| Drug interaction with laboratory Tests. | |||||
| 2 | |||||
| Disorders of calcium metabolism | |||||
| 3 | |||||
| Acid- Base Disorders. | |||||
| 4 | |||||
| Initial Evaluation and Management of the Poisoned Patient. | 3 | ||||
| Including pediatric poisoning and special consideration in the geriatric patient | |||||
| Drug Toxicity: Over the counter drugs; caffeine; theophylline; | 3 | ||||
| antihistamine and decongestant; non-steroidal anti-inflammatory drugs; vitamins. | |||||
| Prescription Medications: Cardiovascular drugs; beta blockers; ACE | 13 | ||||
| inhibitors; Digoxin; Calcium channel blocker; Antiarrhythmic agents; hypoglycemic drugs; Opiods; CNS depressants; tricyclic antidepressants; anti-cholinergic phenothiazines; CNS stimulant. | |||||
| Clinical Toxicology | Drug of Abuse: Opioids; Cocaine; phencyclidine; marijuana; Lysergic acid. | 4 | |||
| Chemical and Environmental Toxins: Hydrocarbones; Household | 3 | ||||
| toxins; Antiseptic; Disinfectants; Camphor; moth repellents. | |||||
| Botanicals and plants-derived toxins: Herbal preparation; Toxic | 4 | ||||
| plants; | |||||
| Poisonous mushrooms. | |||||
| Project. | ( 1 | ||||
| عورفلا عيمج | hours ) | ||||
| , | |||||
| Pharmacoeconomy | Course overview & basic principle of pharmacoeconomics | 2 | |||
| Cost analysis | 6 | ||||
| Cost effectiveness analyses (CEA). | 2 | ||||
| 1st mid-term examination. | 2 | ||||
| Cost utility analyses (CUA). | 2 | ||||
| Cost-benefit analysis (CBA) | 2 | ||||
| Critical assessment of economic evaluation | 4 | ||||
| 2nd mid-term examination. | 2 | ||||
| Drug-focused versus disease-focused frame work for | |||||
| conducting | |||||
| pharmacoeconomic analyses. | 2 | ||||
| Introduction to epidemiology. | 2 | ||||
| Project presentation. | 2 | ||||
| Project presentation. | 2 | ||||
| Therapeutic Drug Monitoring | Review of basic pharmacokinetic (PK) and pharmacodynamic | ||||
| (PD) | 2 | ||||
| Clinical PK equations and calculations | 3 | ||||
| Clinical PK in special population and cases | 3 | ||||
| Clinical PK/PD for Aminoglycosides | 2 | ||||
| Clinical PK/PD for Vancomycin | 2 | ||||
| Clinical PK/PD for Digoxin | 2 | ||||
| Clinical PK/PD for Phenytoin | 3 | ||||
| Clinical PK/PD for other Anticonvulsants (e.g., Carbamazepine, Valproic Acid, Phenobarbitone/Primidone, Ethosuxsimide | |||||
| 3 | |||||
| Clinical PK/PD for Theophylline | 2 | ||||
| Clinical PK/PD for Immunossprasants (e.g., Cyclosporine, | |||||
| Tacrolimus | 2 | ||||
| Clinical PK/PD for other Cardiovascular agents (e.g., Lidocaine, Procainamide/N-Acetyl Procainamide | |||||
| 2 | |||||
| Clinical PK/PD of other drugs (e.g., Lithium), Anticancer agents, and Anticoagulats | |||||
| 4 | |||||
| Clinical Pharmacy Practice in Internal Medicine: Clinical observation of | |||||
| 10 | |||||
| cases; evaluation of the case sheets; case presentation; discussion and | |||||
| evaluation. | |||||
| Clinical Pharmacy Practice in Surgery wards: Clinical observation of | |||||
| cases; evaluation of the case sheets; case presentation; discussion and | 5 | ||||
| Hospital Training | evaluation. | ||||
| Clinical Pharmacy Practice in Gynecology and Obstetrics Ward: | |||||
| Clinical observation of cases; evaluation of the case sheets; case presentation; discussion and evaluation. | 5 | ||||
| Clinical Pharmacy Practice in Pediatric Ward: Neurology , Cardiology , GIT , Birth defects , Sepesis , Meningitis | |||||
| 10 | |||||
| Thyroid and parathyroid disorders | 2 | ||||
| Contraception | 1 | ||||
| Endometriosis | 1 | ||||
| Menstruation related disorders | 1 | ||||
| Therapeutic II | Hormonal replacement therapy (HRT) | 2 | |||
| Cancer treatment and chemotherapy | 2 | ||||
| Leukemias | 2 | ||||
| Lymphomas and Multiple myeloma | 2 | ||||
| Breast and prostate cancers | 2 | ||||
| Adverse effects of chemotherapy | 1 | ||||
| Human immunodeficiency viruse | 2 | ||||
| Adrenal gland disorders | 1 | ||||
| Pituitary gland disorders | 1 | ||||
| Alzheimer’s disease | 1 | ||||
| Schizophrenia | 2 | ||||
| Depressive disorders | 2 | ||||
| Anxiety disorders | 1 | ||||
| Sleep disorders | 1 | ||||
| Bipolar disorders | 2 | ||||
| colorectal cancer | 1 | ||||
| Diagnostic test basics, collecting &transporting specimens, | 4 | ||||
| venipuncture, urine specimen, stool specimen. | |||||
| Biochemical tests: Fasting blood glucose, Post-prandial glucose, Oral | 4 | ||||
| glucose tolerance test. | |||||
| Blood urea, Blood creatinine, Creatinine clearance, Uric acid. | 4 | ||||
| Cholesterol, Lipoproteins, triglycerides. | 4 | ||||
| Blood proteins, Bilirubin. | 4 | ||||
| Calcium, Inorganic phosphate, Serum chloride | 4 | ||||
| Alkaline phosphatase, Acid phosphatase, Alanine amiotransferase, | 4 | ||||
| Aspartate aminotransferase, Lactate dehydrogenase, Creatine phosphokinase. | |||||
| Serological tests: VDRL, ASO- Titer, Hepatitis tests. | 4 | ||||
| Clinical Laboratory Training | C-reactive protein test, Rheumatic factor test, Rosebengal test, | 4 | |||
| Typhoid | |||||
| fever test( Widal test), Pregnancy Test. | |||||
| General urine examination, urine specimen collection. | 4 | ||||
| Hematological tests: RBC count, Hb, PCV, RBC indices, WBC | 4 | ||||
| count, | |||||
| Platelets count. | |||||
| Blood typing, Coombs test, Bleeding time, ESR. | 4 | ||||
| Microbiological tests: culture and sensitivity tests, Staining methods | 4 | ||||
| Culture media, Enriched culture media for general use | 4 | ||||
| Tests for identification of bacteria, Disk diffusion tests of sensitivity | 4 | ||||
| to | |||||
| antibiotics, Choice of drugs for disk test, bacterial disease and their laboratory diagnosis. | |||||
| Biotechnology – introduction | 1 | ||||
| Formulation of biotechnology product (biopharmaceutical | 4 | ||||
| consideration) Microbial consideration- sterility-pyrogen viral decontamination Excipients of parentral products – solubility enhancer-anti adsorption agents buffer components-preservatives – osmotic agents | |||||
| pharmaceutical biotechnology | Route of administration Parentral route Oral route Alternative | 5 | |||
| routes ( nasal-pulmonary-rectal-buccal transdermal ) | |||||
| Pharmacokinetic of peptides and proteins Introduction Elimination | 5 | ||||
| of proteins (proteolysis-excretion-metabolism ) | |||||
| Pharmaceutical consideration: The need for the dosage form. | 1 | ||||
| General consideration for the dosage form. | 3 | ||||
| Pre-formulation; physical description, microscopic examination. | 2 | ||||
| Melting point; phase rule; particle size; polymorphism; solubility. | 2 | ||||
| Permeability; pH; partition coefficient; pka; stability; kinetics; shelf | 2 | ||||
| life. | |||||
| Rate reaction; enhancing stability. | 2 | ||||
| Formulation consideration: Excipients; definition and types; | 2 | ||||
| appearance; palatability; flavoring. | |||||
| Sweetening; coloring pharmaceuticals; preservatives; sterilization; | 2 | ||||
| preservatives selection. | |||||
| Dosage form Design | Biopharmaceutical considerations: Principle of drug absorption; | 4 | |||
| dissolution of the drugs. | |||||
| Bioavailability and bioequivalancy; FDA requirements. | 3 | ||||
| Assessment of bioavailability; bioequivalence among drug products. | 3 | ||||
| Pharmacokinetic principles: Half life; clearance; dosage regimen | 4 | ||||
| considerations. | |||||
| UV / visible spectroscopy; Sample handling and instrumentation; | 6 | ||||
| Characteristic absorption of organic compounds; Rules for calculation of lambda max and application; Application of UV/visible; spectroscopy; Problems and solutions. | |||||
| Advanced Pharmaceutical Analyses | |||||
| Infra Red spectroscopy (theory and H-bonding effect; Sampling | 14 | ||||
| techniques and interpretation of spectra; Characteristic group frequencies of organic compounds; Application of IR spectroscopy; Problems and solutions. | |||||
| H1 –Nucleomagnetic Resonance (NMR) and C13-NMR spectroscopy; | 12 | ||||
| Introduction, the nature of NMR absorption, chemical shifts and factors affecting them, information obtained from NMR spectra, more complex spin-spin splitting patterns, application of H1-NMR spectroscopy; | |||||
| C13-NMR spectroscopy: introduction and characteristics, DEPT C13- NMR spectroscopy. | |||||
| Mass spectroscopy: Introduction and interpreting Mass spectra; | 11 | ||||
| interpreting Mass spectra fragmentation patterns, Mass behavior of some common functional groups. | |||||
| elemental microanalysis CHNSO | 2 | ||||



